Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (AVHHL) Gains from Sales and Divestitures (2021 - 2025)

Historic Gains from Sales and Divestitures for AVITA Medical (AVHHL) over the last 5 years, with Q3 2025 value amounting to $109180.0.

  • AVITA Medical's Gains from Sales and Divestitures fell 2075.43% to $109180.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $109180.0, marking a year-over-year decrease of 2075.43%. This contributed to the annual value of $235059.0 for FY2023, which is 7731.2% up from last year.
  • AVITA Medical's Gains from Sales and Divestitures amounted to $109180.0 in Q3 2025, which was down 2075.43% from $76724.0 recorded in Q2 2025.
  • Over the past 5 years, AVITA Medical's Gains from Sales and Divestitures peaked at $235059.0 during Q4 2023, and registered a low of $14608.0 during Q1 2025.
  • Over the past 5 years, AVITA Medical's median Gains from Sales and Divestitures value was $92650.0 (recorded in 2023), while the average stood at $103913.5.
  • The largest annual percentage gain for AVITA Medical's Gains from Sales and Divestitures in the last 5 years was 26528.48% (2022), contrasted with its biggest fall of 6126.27% (2022).
  • Over the past 5 years, AVITA Medical's Gains from Sales and Divestitures (Quarter) stood at $28754.0 in 2021, then skyrocketed by 361.04% to $132568.0 in 2022, then soared by 77.31% to $235059.0 in 2023, then tumbled by 41.39% to $137774.0 in 2024, then dropped by 20.75% to $109180.0 in 2025.
  • Its last three reported values are $109180.0 in Q3 2025, $76724.0 for Q2 2025, and $14608.0 during Q1 2025.